On August 14, 2024, the US District Court for the District of Delaware entered final judgment in Wyeth—a patent infringement case relating to pharmaceuticals for treating non-small cell lung cancer (“NSCLC”)—vacating a jury...more
Over the last several months, the United States Patent and Trademark Office (“USPTO”) publicized its attention to the impact of artificial intelligence on U.S. patent practice. On February 6, 2024, the USPTO issued its...more
On May 18, 2023, the Supreme Court of the United States issued its decision in Amgen Inc. v. Sanofi, 22-157, ___ U.S. ___ (2023) (available here). The Court decided that patent claims directed toward a genus of antibodies...more